Management of a thyroid "incidentaloma" in a patient with cancer: a case report.
The routine use of (18)F-fluorodeoxyglucose-positron emission tomography (PET)/computed tomography scans for staging and assessment of treatment response for cancer has resulted in a large number of thyroid abnormalities being detected as incidental findings ("incidentalomas"). Since most PET/CT scans are performed in the setting of a known nonthyroid malignancy, the need for "incidentalomas" to be further investigated and managed depends on the stage, prognosis, and current treatment plan for the known malignancy. We present a case describing the management of an incidental F-fluorodeoxyglucose-avid thyroid nodule detected in a patient with known metastatic colorectal cancer. On the basis of this case, we discuss the management of incidental PET-detected thyroid nodules in patients with metastatic cancer. Thyroid "incidentalomas" must be seen in the context of the prognosis and treatment plan for the known malignancy.
Department of Oncology, Oxford University Hospitals NHS Trust, University of Oxford, Oxford, UK.
Charles
C
Dearman
Department of Oncology, Oxford University Hospitals NHS Trust, University of Oxford, Oxford, UK.
Esme J
EJ
Hill
Department of Oncology, Oxford University Hospitals NHS Trust, University of Oxford, Oxford, UK.
Jamie M
JM
Franklin
Department of Endocrine Surgery, Oxford University Hospitals NHS Trust, University of Oxford, Oxford, UK.
Greg P
GP
Sadler
Department of Histopathology and Hepatobiliary Surgery, Oxford University Hospitals NHS Trust, University of Oxford, Oxford, UK.
Lai Mun
LM
Wang
Department of Histopathology and Hepatobiliary Surgery, Oxford University Hospitals NHS Trust, University of Oxford, Oxford, UK.
Michael A
MA
Silva
CRUK-MRC Oxford Institute for Radiation Oncology, NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Trust, University of Oxford, Oxford, UK.
Ricky A
RA
Sharma
PET; cancer; imaging; metastasis; morbidity; surgery